Foundation for innovation
in Cardiometabolism and Nutrition

Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC

Clinics and Research in Hepatology and Gastroenterology

Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC

Posted on 

ISO 9001 Certified

OUr Institutionnal Supporters

Our network